What concerns me when I take the frightening move of trying to get inside the shrunken heads of the Trump administration is that they will initiate a federal schedule move to Schedule II, which would hand the entire industry over to Big Pharma. They could then market it to the public as "compassionately legalizing medical marijuana." That could give Trump some leverage to fulfill a campaign promise if he negotiated lowering *some* pharmaceutical drug prices in exchange for the windfall of giving pharma access to what they certainly see as their biggest potential future competitor.